Kimitaka Shibue, Ph.D., M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Gastric Inhibitory Polypeptide | 6 | 2017 | 48 | 1.200 |
Why?
|
Enteroendocrine Cells | 5 | 2017 | 57 | 1.020 |
Why?
|
Hypopituitarism | 1 | 2017 | 249 | 0.580 |
Why?
|
Insulinoma | 1 | 2013 | 120 | 0.510 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2015 | 320 | 0.480 |
Why?
|
Dietary Fats | 3 | 2017 | 2078 | 0.350 |
Why?
|
Hypoglycemia | 1 | 2013 | 769 | 0.330 |
Why?
|
Glucose Intolerance | 2 | 2021 | 581 | 0.260 |
Why?
|
Adrenocortical Carcinoma | 1 | 2022 | 76 | 0.220 |
Why?
|
Neoplasm Proteins | 1 | 2015 | 3972 | 0.220 |
Why?
|
Glucagon-Secreting Cells | 1 | 2021 | 53 | 0.220 |
Why?
|
Adrenal Cortex Neoplasms | 1 | 2022 | 147 | 0.210 |
Why?
|
Obesity | 4 | 2017 | 11700 | 0.200 |
Why?
|
Receptors, Gastrointestinal Hormone | 2 | 2017 | 39 | 0.200 |
Why?
|
Insulin Resistance | 3 | 2021 | 3808 | 0.200 |
Why?
|
Glucagon | 1 | 2021 | 541 | 0.190 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 2021 | 587 | 0.180 |
Why?
|
Adrenalectomy | 2 | 2017 | 333 | 0.180 |
Why?
|
Glutamine | 1 | 2021 | 576 | 0.180 |
Why?
|
Receptors, G-Protein-Coupled | 2 | 2017 | 1185 | 0.180 |
Why?
|
Corn Oil | 1 | 2017 | 29 | 0.180 |
Why?
|
Addison Disease | 1 | 2017 | 49 | 0.170 |
Why?
|
Calgranulin A | 1 | 2018 | 81 | 0.170 |
Why?
|
Cushing Syndrome | 1 | 2019 | 245 | 0.170 |
Why?
|
Cholecystokinin | 1 | 2017 | 107 | 0.170 |
Why?
|
Gastrointestinal Hormones | 1 | 2017 | 103 | 0.160 |
Why?
|
Pancreatic Neoplasms | 1 | 2013 | 5015 | 0.150 |
Why?
|
Hyperaldosteronism | 1 | 2015 | 215 | 0.130 |
Why?
|
Octreotide | 1 | 2013 | 154 | 0.120 |
Why?
|
Spironolactone | 1 | 2015 | 356 | 0.120 |
Why?
|
Insulin-Secreting Cells | 2 | 2018 | 974 | 0.120 |
Why?
|
Nephrectomy | 1 | 2017 | 1034 | 0.110 |
Why?
|
Mice, Transgenic | 5 | 2017 | 10094 | 0.110 |
Why?
|
Fatty Liver | 1 | 2017 | 716 | 0.110 |
Why?
|
Glucose | 4 | 2018 | 4016 | 0.110 |
Why?
|
Gastrointestinal Tract | 1 | 2017 | 845 | 0.100 |
Why?
|
Acromegaly | 1 | 2012 | 325 | 0.100 |
Why?
|
Vascular Resistance | 1 | 2012 | 991 | 0.100 |
Why?
|
Intestine, Small | 1 | 2014 | 1281 | 0.090 |
Why?
|
Eating | 1 | 2015 | 1429 | 0.090 |
Why?
|
Glucose Tolerance Test | 3 | 2017 | 1162 | 0.090 |
Why?
|
Prednisolone | 2 | 2019 | 335 | 0.090 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2019 | 1997 | 0.080 |
Why?
|
Interleukin-6 | 1 | 2017 | 3105 | 0.080 |
Why?
|
RNA, Messenger | 3 | 2017 | 13469 | 0.080 |
Why?
|
Adipose Tissue | 2 | 2017 | 3232 | 0.070 |
Why?
|
Macrophages | 1 | 2018 | 5748 | 0.060 |
Why?
|
Cells, Cultured | 2 | 2018 | 20620 | 0.060 |
Why?
|
Mice | 7 | 2021 | 80803 | 0.060 |
Why?
|
Gene Knock-In Techniques | 2 | 2014 | 467 | 0.060 |
Why?
|
Blood Glucose | 2 | 2013 | 6125 | 0.060 |
Why?
|
Mice, Knockout | 4 | 2021 | 15597 | 0.060 |
Why?
|
Insulin | 2 | 2013 | 6521 | 0.050 |
Why?
|
Animals | 10 | 2021 | 170849 | 0.050 |
Why?
|
Atherosclerosis | 1 | 2015 | 2958 | 0.050 |
Why?
|
Apoptosis | 1 | 2018 | 10261 | 0.050 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2021 | 298 | 0.050 |
Why?
|
Liver | 1 | 2017 | 7653 | 0.050 |
Why?
|
Disease Progression | 1 | 2017 | 13204 | 0.050 |
Why?
|
Adrenocortical Adenoma | 1 | 2019 | 37 | 0.050 |
Why?
|
Glucocorticoids | 2 | 2019 | 2100 | 0.050 |
Why?
|
Palmitates | 1 | 2018 | 79 | 0.040 |
Why?
|
Inflammation | 1 | 2018 | 9617 | 0.040 |
Why?
|
Hyaluronic Acid | 1 | 2021 | 497 | 0.040 |
Why?
|
Green Fluorescent Proteins | 2 | 2014 | 2238 | 0.040 |
Why?
|
Male | 10 | 2021 | 352465 | 0.040 |
Why?
|
3T3-L1 Cells | 1 | 2017 | 223 | 0.040 |
Why?
|
Transcription Factors | 2 | 2017 | 11910 | 0.040 |
Why?
|
Signal Transduction | 5 | 2021 | 24351 | 0.040 |
Why?
|
Lupus Nephritis | 1 | 2019 | 316 | 0.040 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2017 | 386 | 0.040 |
Why?
|
Sesterterpenes | 1 | 2014 | 9 | 0.040 |
Why?
|
Glucagon-Like Peptide 1 | 1 | 2017 | 290 | 0.040 |
Why?
|
Hypokalemia | 1 | 2015 | 157 | 0.040 |
Why?
|
Salicylates | 1 | 2014 | 133 | 0.030 |
Why?
|
Metabolome | 1 | 2021 | 825 | 0.030 |
Why?
|
Locomotion | 1 | 2017 | 368 | 0.030 |
Why?
|
DNA-Binding Proteins | 1 | 2012 | 9934 | 0.030 |
Why?
|
Toll-Like Receptor 4 | 1 | 2018 | 567 | 0.030 |
Why?
|
Mice, Inbred C57BL | 3 | 2018 | 23439 | 0.030 |
Why?
|
Body Weight | 2 | 2017 | 4804 | 0.030 |
Why?
|
Aged | 5 | 2017 | 162271 | 0.030 |
Why?
|
Cell Count | 1 | 2017 | 1974 | 0.030 |
Why?
|
Humans | 10 | 2022 | 686663 | 0.030 |
Why?
|
Intestinal Mucosa | 2 | 2014 | 3116 | 0.030 |
Why?
|
Potassium | 1 | 2015 | 1437 | 0.030 |
Why?
|
Japan | 1 | 2015 | 1314 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2019 | 60991 | 0.030 |
Why?
|
Aldosterone | 1 | 2015 | 852 | 0.030 |
Why?
|
Hydrocortisone | 1 | 2017 | 1737 | 0.030 |
Why?
|
Drug Monitoring | 1 | 2015 | 941 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 4076 | 0.020 |
Why?
|
Phosphorylation | 1 | 2021 | 8896 | 0.020 |
Why?
|
Genes, Reporter | 1 | 2012 | 1659 | 0.020 |
Why?
|
Disease Management | 1 | 2019 | 2586 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2017 | 1995 | 0.020 |
Why?
|
Human Growth Hormone | 1 | 2012 | 662 | 0.020 |
Why?
|
Fasting | 1 | 2013 | 1573 | 0.020 |
Why?
|
Adult | 4 | 2015 | 211400 | 0.020 |
Why?
|
Comorbidity | 1 | 2021 | 10648 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 5114 | 0.020 |
Why?
|
Down-Regulation | 1 | 2014 | 3226 | 0.020 |
Why?
|
Cholesterol, HDL | 1 | 2012 | 1768 | 0.020 |
Why?
|
Energy Metabolism | 1 | 2017 | 2953 | 0.020 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2012 | 2017 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2012 | 4129 | 0.020 |
Why?
|
Carcinoma, Renal Cell | 1 | 2017 | 2911 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2021 | 16227 | 0.020 |
Why?
|
Cholesterol, LDL | 1 | 2012 | 2228 | 0.020 |
Why?
|
Risk | 1 | 2015 | 9915 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2012 | 3713 | 0.020 |
Why?
|
Cell Line | 1 | 2018 | 17137 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2017 | 12095 | 0.010 |
Why?
|
Kidney Neoplasms | 1 | 2017 | 4017 | 0.010 |
Why?
|
Female | 5 | 2021 | 375459 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2012 | 6150 | 0.010 |
Why?
|
Protein Binding | 1 | 2012 | 9947 | 0.010 |
Why?
|
Gene Expression | 1 | 2012 | 8182 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2015 | 19308 | 0.010 |
Why?
|
Hypertension | 1 | 2015 | 7941 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2014 | 12680 | 0.010 |
Why?
|
Middle Aged | 3 | 2015 | 216468 | 0.010 |
Why?
|
Risk Factors | 1 | 2021 | 69278 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2015 | 39737 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2013 | 21640 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2017 | 20409 | 0.010 |
Why?
|
Adolescent | 1 | 2019 | 84957 | 0.010 |
Why?
|
Time Factors | 1 | 2013 | 42271 | 0.010 |
Why?
|